期刊文献+

IL-6和IL-11对脐血CD34^+细胞诱导分化为巨核细胞的影响 被引量:3

Effects of IL-6 and IL-11 on differentiation of cord blood CD34^+ cells towards megakaryocytes
下载PDF
导出
摘要 目的:探讨白细胞介素-6(IL-6)和白细胞介素-11(IL-11)对脐血CD34+细胞诱导分化为巨核细胞及其产生血小板的影响。方法:采用免疫磁珠法(MACS)分选8例健康产妇足月顺产的胎儿脐血中CD34+细胞,以含血小板生成素(TPO 50μg/L)、白细胞介素-3(IL-3 10μg/L)、干细胞因子(SCF 50μg/L)的无血清培养基作为对照组,分别添加10μg/L IL-6、IL-11、IL-6+IL-11作为实验组,培养14 d后观察结果。利用细胞计数仪检测单个核细胞数;流式细胞仪计数培养体系中的CD41+细胞和血小板;用倒置显微镜观察培养体系中的细胞生长情况;用显微镜和流式细胞仪观察凝血酶诱导后的血小板凝集情况。结果:各实验组单个核细胞数与对照组无明显区别(P>0.05),而CD41+细胞和血小板数量明显多于对照组(P<0.05)。培养第14 d后倒置显微镜下可见实验组中血小板样颗粒物明显多于对照组,而且经凝血酶诱导后有明显血小板凝集。结论:IL-6和IL-11可诱导脐血中CD34+细胞分化为巨核细胞并产生功能性血小板。 AIM: To investigate the effects of interleukin -6 (IL -6) and interleukin - 11 (IL-11) on differentiation of cord blood CD^34+ cells towards megakaryocytes and platelet production in vitro. METHODS : The CD^34+ cells from fresh umbilical cord blood samples were cuhured in serum -free cuhure medium with thrombopoietin (TPO) 50 μg/L, IL-3 10μg/L, stem cell factor (SCF) 50 μg/L as control groups, then 10 μg/L IL-6 or IL- 11 or IL-6 + IL- 11 respectively was added as treatment groups. Mononuclear cells (MNCs) in cuhured cells were detected by cell counter, megakaryocytes (CD41^ + cells) and platelets were measured by flow cytometry, respectively. Platelet agglutination after thrombin induced was observed by microscopy and flow cytometry. RESULTS: Compared with the control group, the number of MNCs was not significantly different(P 〉0.05 ), but the numbers of CD41^+ cells and platelets were increased significantly (P 〈 0. 05) in treatment groups. There were more platelet particles in treatment groups than those in control group by microscopy and the resuhs also showed that the cytoplasmic fragments from the cultures responded to thrombin induction. CONCLUSION: It is concluded that both IL -6 and IL - 11 induce the cord blood CD^34 + cells to differentiate towards megakaryocytes and produce platelets.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第10期1927-1930,共4页 Chinese Journal of Pathophysiology
基金 浙江省科技厅重点资助项目(No.2006C23032) 浙江省医药卫生优秀青年科技人才专项基金资助项目(No.2002QN005)
关键词 白细胞介素6 白细胞介素11 CD^34+细胞 巨核细胞 血小板 脐血 Interleukin - 6 Interleukin - 11 CD34 ^+ cells Megakaryocytes Blood platelets Cord blood
  • 相关文献

参考文献13

  • 1Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution [ J ]. Haematologica, 2003, 88 ( 4 ) : 379 - 387.
  • 2Charrier S, Boiret N, Fouassier M, et al. Normal human bone marrow CD34( + )CD133( + ) cells contain primitive cells able to produce different categories of colonyforming unit megakaryocytes in vitro [ J ]. Exp Hematol, 2002, 30(9) : 1051 - 1060.
  • 3Cortin V, Gamier A, Pineault N, et al. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design [ J ]. Exp Hematol, 2005, 33(10) : 1182-1191.
  • 4冯义,肖志坚,徐世才,卢士红,刘斌,刘津华,韩忠朝.脐血巨核祖细胞的体外扩增[J].中国医学科学院学报,2005,27(2):199-204. 被引量:3
  • 5De Bruyn C, Delforge A, Martiat P, et al. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood[ J ]. Stem Cells Dev, 2005, 14 (4) : 415-424.
  • 6陈舒,朱发明,何吉,刘晋辉,秦斐,严力行.GM-CSF对脐血CD34^+巨核祖细胞体外扩增及分化的影响[J].中国实验血液学杂志,2005,13(6):1041-1043. 被引量:5
  • 7Balducci E, Azzarello G, Valenti MT, et al. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial[J]. Stem Cells, 2003, 21( 1 ) : 33-40.
  • 8Eto K, Murphy R, Kerrigan SW, et al. Megakaryocytes derived from embryonic stem cells implicate CalDAG - GEFI in integrin signaling[J]. Proc Natl Acad Sci USA, 2002, 99(20) : 12819 - 12824.
  • 9Lazzari L, Henschler R, Lecchi L, et al. Interleukin-6 and interleukin - 11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41 + and CD61 + megakaryocytic cells [ J ]. Haematologica, 2000, 85 (1): 25-30.
  • 10Saitoh M, Taguchi K, Momose K, et al. Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice [J]. Cytokine, 2001, 13(5) : 287-294.

二级参考文献24

  • 1Miyazaki H, Kato T. Thrombopoietin: biology and clinical potentials. Int J Hematol, 1999, 70:216-225.
  • 2Miyazaki H. Physiologic role of TPO in thrombopoiesis.Stem Cells, 1996, 14:133-138.
  • 3Ahmed N, Khokher MA, Hassan HT, et al. Cytokineinduced expansion of human CD34^+ stem/progenitor and CD34^+CD41^+ early megakaryocytic marrow cells cultured on normal osteoblasts. Stem Cells, 1999, 17:92-99.
  • 4Woo SY, Kie JH, Ryu KH, et al. Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Scand J Immunol, 2002, 55:88 -95.
  • 5Li K, Yang M, Lam AC, et al. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant, 2000, 9(1):125-131.
  • 6Broxmeyer HE, Lu L, Cooper S, et al. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp Hematol, 1995, 23(10):1121-1129.
  • 7Miyazaki R, Ogata H, Iguchi T, et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haemato, 2000, 108(3):602-609.
  • 8Tao H, Gaudry L, Rice A, et al. Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol, 1999, 27(2):293-301.
  • 9Han ZC, Bellucci S, Shen ZX, et al. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth factors. J Cell Physiol, 1996, 168:97-104.
  • 10Paquette RL, Dergham ST, Karpf E, et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood, 2000, 96(7):2385-2390.

共引文献28

同被引文献20

  • 1唐锁勤,杨光,王建文,黄东生,于芳,刘英.重组人白细胞介素-11防治神经母细胞瘤患儿强烈化疗后血小板减少的自身对照研究[J].实用儿科临床杂志,2005,20(7):657-659. 被引量:3
  • 2宋丽楠,刘巍.化疗后血小板减少症的治疗进展[J].现代肿瘤医学,2007,15(2):281-283. 被引量:25
  • 3Taguchi K, Saitoh M, Arai Y, et al. Disparate effects of interleukinl 1 and thrombopoietin on megakaryocytopoiesis in vitro[J]. Cytokine, 2001, 15(5):241-249.
  • 4Bhatia M, Davenport V, Cairo MS. The role of interleukin- 11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes [J]. Leuk Lymphoma, 2007, 48(1):9-15.
  • 5Tsimberidou AM,Giles FJ, Khouri I, et al. Low-dose interleukin-11 in patients with bone marrow failure:update of the M.D.Anderson Cancer Center experience [J]. Ann Oncol, 2005, 16(1):139-145.
  • 6Montero AJ, Estrov Z, Freireich E J, et al. Phase Ⅱ study of low-dose interleukin-11 in patients with myelodysplastic syndrome[J]. Leuk Lymphoma, 2006, 47(10):2049-2054.
  • 7Cairo MS, Davenport V, Bessmertny O, et al. Phase Ⅰ /Ⅱ dose escalation study of recombinant human interleukin- 11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study [J]. Br J Haematol, 2005, 128(1):49-58.
  • 8顾龙君.儿童急性淋巴细胞白血病[M] //施诚仁.小儿肿瘤.北京大学医学出版社,2007:107-154.
  • 9Bhatia M,Davenport V,Cairo MS.The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors,lymphoma,acute myeloid leukemia and bone marrow failure syndromes[J].Leuk Lymphoma,2007,48 (1):9-15.
  • 10Reynolds CH.Clinical efficacy of rhIL-11[J].Oncology (Williston Park),2000,14(9 Suppl 8):32-40.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部